REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Insunefro S.A. (Ecuador)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Health and Personal Care Stores
Full name: Insunefro S.A. Profile Updated: May 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Insunefro S.A. is based in Ecuador, with the head office in Guayaquil. The company operates in the Pharmacies and Drug Stores industry. It was first established on September 22, 2017. Insunefro S.A. currently employs 4 (2023) people. From the latest financial highlights, Insunefro S.A. reported a net sales revenue drop of 51.33% in 2023. Its’ total assets recorded a negative growth of 6.93%. In 2023, Insunefro S.A.’s net profit margin decreased by 12.55%.

Headquarters
Calle G 605
Guayaquil; Guayas;

Contact Details: Purchase the Insunefro S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Insunefro S.A. report to view the information.
Outstanding Shares:
Purchase the Insunefro S.A. report to view the information.
Registered Capital:
Purchase the Insunefro S.A. report to view the information.
Incorporation Date:
September 22, 2017
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99.88%
Purchase this report to view the information.
0.12%
Company Performance
Financial values in the chart are available after Insunefro S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-51.33%▼
Total operating revenue
-51.33%▼
Operating profit (EBIT)
-76.16%▼
Net Profit (Loss) for the Period
-88.7%▼
Total assets
-6.93%▼
Total equity
26.95%▲
Operating Profit Margin (ROS)
-11.61%▼
Net Profit Margin
-12.55%▼
Return on Equity (ROE)
-81.6%▼
Debt to Equity Ratio
-0.12%▼
Quick Ratio
-0.15%▼
Cash Ratio
-0.02%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo